...
首页> 外文期刊>Ancient Science of Life >PA01.25. Clinical evaluation of chitrakadi churna and kshar basti in the management of amavata with special reference to rheumatoid arthritis
【24h】

PA01.25. Clinical evaluation of chitrakadi churna and kshar basti in the management of amavata with special reference to rheumatoid arthritis

机译:PA01.25。 Chitrakadi Churna和kshar basti在风湿性关节炎特别是类风湿关节炎治疗中的临床评估

获取原文
           

摘要

Purpose: The disease Amavata can be presented as very similar to Rheumatoid Arthritis. Rheumatoid Arthritis is chronic in nature and affects mostly middle aged people. For this disease there is no satisfactory medicine is available till date. But in Ayurveda there are many drugs described for Amavata which are cost effective and easily available with no side effects. The present clinical study evaluated the effect of Chitrakadi Churna and Kshar Basti in the management of Amavata. Method: 30 clinically diagnosed patient of Amavata were registered and completed the trial. In this 15 patients (Group A) administered Chitrakadi Churna 4gm twice daily with lukewarm water after meal. Another 15 patients (Group B) administered Chitrakadi Churna 4gm twice daily with lukewarm water after meal and Kshar Basti as per Kalbasti krama i.e 16days followed by local Snehan Swedan. Result: Results of this trial were encouraging as there is improvement in each symptom of patient like pain, stiffness, swelling, and tenderness. Group A in which only Chitrakadi Churna was administered there was no significant improvement seen statistically. But Group B in which Chitrakadi Churna as well as Kshar Basti was administered highly significant improvement seen statistically. Details of the Statistical test and other important will be discussed at the time of paper presentation. Conclusion: From present clinical trial it is concluded that this therapy is very useful for pain, swelling, tenderness and stiffness, which were chief complaint of the patient. Chronicity more than 3 years did not show marked improvement. And also this drug is supposed to be very good combination of Vedanashamaka, Shothaghna, Amapachaka Dravyas. No untoward effects were seen except mild loss of weight.
机译:目的:阿马瓦塔病可与类风湿关节炎非常相似。类风湿关节炎本质上是慢性的,主要影响中年人。对于这种疾病,迄今为止尚无令人满意的药物。但是在阿育吠陀中,有许多关于Amavata的药物描述,这些药物具有成本效益且易于获得,且无副作用。本临床研究评估了Chitrakadi Churna和Kshar Basti在Amavata治疗中的作用。方法:对30名经临床诊断的Amavata患者进行注册并完成试验。在这15名患者(A组)中,饭后每天两次给Chitrakadi Churna 4gm服用温水。另有15名患者(B组)每天两次在饭后服用Chitrakadi Churna 4gm,并根据Kalbasti krama服用Kshar Basti,即16天,然后是当地的Snehan Swedan。结果:该试验的结果令人鼓舞,因为患者的每种症状(例如疼痛,僵硬,肿胀和压痛)都有改善。仅施用Chitrakadi Churna的A组在统计学上未见明显改善。但是,从统计学上看,在B组中对Chitrakadi Churna和Kshar Basti进行了高度显着改善。统计测试和其他重要测试的详细信息将在论文发表时进行讨论。结论:从目前的临床试验可以得出结论,该疗法对于疼痛,肿胀,压痛和僵硬非常有用,这是患者的主要主诉。超过3年的慢性病没有显示出明显的改善。而且这种药物也应该是吠陀那沙那卡,Shothaghna和阿玛帕查卡德拉维雅斯的很好的组合。除轻度减轻体重外,未见不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号